Literature DB >> 22517863

Structure of an intermediate state in protein folding and aggregation.

Philipp Neudecker1, Paul Robustelli, Andrea Cavalli, Patrick Walsh, Patrik Lundström, Arash Zarrine-Afsar, Simon Sharpe, Michele Vendruscolo, Lewis E Kay.   

Abstract

Protein-folding intermediates have been implicated in amyloid fibril formation involved in neurodegenerative disorders. However, the structural mechanisms by which intermediates initiate fibrillar aggregation have remained largely elusive. To gain insight, we used relaxation dispersion nuclear magnetic resonance spectroscopy to determine the structure of a low-populated, on-pathway folding intermediate of the A39V/N53P/V55L (A, Ala; V, Val; N, Asn; P, Pro; L, Leu) Fyn SH3 domain. The carboxyl terminus remains disordered in this intermediate, thereby exposing the aggregation-prone amino-terminal β strand. Accordingly, mutants lacking the carboxyl terminus and thus mimicking the intermediate fail to safeguard the folding route and spontaneously form fibrillar aggregates. The structure provides a detailed characterization of the non-native interactions stabilizing an aggregation-prone intermediate under native conditions and insight into how such an intermediate can derail folding and initiate fibrillation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517863     DOI: 10.1126/science.1214203

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  130 in total

1.  Population shuffling between ground and high energy excited states.

Authors:  T Michael Sabo; John O Trent; Donghan Lee
Journal:  Protein Sci       Date:  2015-10-15       Impact factor: 6.725

2.  Preventing fibril formation of a protein by selective mutation.

Authors:  Gia G Maisuradze; Jordi Medina; Khatuna Kachlishvili; Pawel Krupa; Magdalena A Mozolewska; Pau Martin-Malpartida; Luka Maisuradze; Maria J Macias; Harold A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

3.  Force-dependent switch in protein unfolding pathways and transition-state movements.

Authors:  Pavel I Zhuravlev; Michael Hinczewski; Shaon Chakrabarti; Susan Marqusee; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-27       Impact factor: 11.205

4.  Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.

Authors:  Santosh V Thakkar; Neha Sahni; Sangeeta B Joshi; Bruce A Kerwin; Feng He; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2013-08-19       Impact factor: 6.725

5.  NMR paves the way for atomic level descriptions of sparsely populated, transiently formed biomolecular conformers.

Authors:  Ashok Sekhar; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-18       Impact factor: 11.205

6.  Conformer-specific characterization of nonnative protein states using hydrogen exchange and top-down mass spectrometry.

Authors:  Guanbo Wang; Rinat R Abzalimov; Cedric E Bobst; Igor A Kaltashov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

7.  Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein.

Authors:  Santiago Esteban-Martín; Jordi Silvestre-Ryan; Carlos W Bertoncini; Xavier Salvatella
Journal:  Biophys J       Date:  2013-09-03       Impact factor: 4.033

8.  Pressure-induced structural transition of mature HIV-1 protease from a combined NMR/MD simulation approach.

Authors:  Julien Roche; John M Louis; Ad Bax; Robert B Best
Journal:  Proteins       Date:  2015-10-16

9.  A methyl 1H double quantum CPMG experiment to study protein conformational exchange.

Authors:  Anusha B Gopalan; Tairan Yuwen; Lewis E Kay; Pramodh Vallurupalli
Journal:  J Biomol NMR       Date:  2018-10-01       Impact factor: 2.835

10.  Early folding events protect aggregation-prone regions of a β-rich protein.

Authors:  Ivan L Budyak; Beena Krishnan; Anna M Marcelino-Cruz; Mylene C Ferrolino; Anastasia Zhuravleva; Lila M Gierasch
Journal:  Structure       Date:  2013-03-05       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.